The Journal of Heart and Lung Transplantation
Volume 27, Issue 12 , Pages 1340-1347, December 2008

Human, Bovine and Porcine Systematic Vascular Input Impedances Are Not Equivalent: Implications for Device Testing and Xenotransplantation in Heart Failure

Cardiovascular Innovation Institute, Department of Bioengineering and Surgery, University of Louisville, Louisville, Kentucky

Received 18 December 2007; received in revised form 16 May 2008; accepted 21 August 2008.

Background

Advanced therapies for heart failure (HF), such as mechanical circulatory support (MCS) devices and xenotransplantation, are usually tested in bovine and porcine models. This approach assumes a priori that animal (patho)physiology will closely match that of humans. Systemic aortic input impedance (ZART) is an important physiologic determinant of left ventricular (LV) performance. We tested the hypothesis that ZART is lower in bovine and porcine than in humans with normal or failing hearts.

Methods

High-fidelity aortic pressure and flow waveforms were recorded intra-operatively at native and paced heart rates of 100 beats per minute (bpm) in adult human patients with normal LV function (n = 13) or end-stage HF (n = 15), and normal calves (n = 10) and pigs (n = 18). Fast Fourier transformation was used to calculate ZART, and arterial resistance and compliance were estimated using a 4-element Windkessel model.

Results

Humans with HF had greater ZART than those with normal LV function, characterized by higher resistance (1.16 ± 0.12 vs 1.00 ± 0.10 mm Hg·s/ml, p < 0.05) and lower compliance (1.53 ± 0.21 vs 1.88 ± 0.33 ml·mm Hg, p < 0.05). Healthy calves and pigs had significantly lower resistance (calf: 0.63 ± 0.07 mm Hg·s/ml; pig: 0.90 ± 0.07 mm Hg·s/ml) and higher compliance (calf: 2.79 ± 0.37 ml·mm Hg; pig: 2.80 ± 0.64 ml·mm Hg) when compared to humans (p < 0.05) with normal or failing hearts.

Conclusions

ZART is significantly lower in calves and pigs than in humans with or without HF. This finding has important implications for the pre-clinical testing of MCS devices and xenotransplants, which are usually examined in bovine and porcine models, respectively. Specifically, these therapies may respond differently in humans than animals due to non-equivalence of systemic after-load.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by funding from the American Heart Association Ohio Valley Affiliate (grant no. 0060250B) and the Whitaker Foundation (grant no. RG-01-0310).

PII: S1053-2498(08)00620-7

doi:10.1016/j.healun.2008.08.009

The Journal of Heart and Lung Transplantation
Volume 27, Issue 12 , Pages 1340-1347, December 2008